Holen Sie sich die Stockscreener-App
78.00
2.01%
1.54
Handel nachbörslich:
78.26
0.26
+0.33%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Is Merck & Co., Inc. (MRK) the Best Large-Cap Value Stock to Buy as the Recession Hits? - Insider Monkey
MERCK ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Assessing Merck & Co: Insights From 9 Financial Analysts - Benzinga
Is Merck & Co., Inc. (MRK) The Dirt Cheap Stock To Invest In Now? - Yahoo Finance
BMO Capital Adjusts Merck Price Target to $89 From $96 - MarketScreener
Leerink Partners Adjusts Price Target on Merck to $115 From $113, Keeps Outperform Rating - MarketScreener
Merck & Co., Inc. (MRK): Among the Innovative Healthcare Stocks to Watch in 2025 - Insider Monkey
Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock - Yahoo Finance
Companion Animal Medicine Market Top PlayersMerck & Co., Inc.; - openPR.com
Empyema Market Deep Research Report with Forecast by 2032 | Pfizer Inc.,Merck & Co., Inc.,GlaxoSmithKline plc - openPR.com
Is Merck & Co., Inc. (MRK) the Best Pharma Stock to Buy for Long Term Growth? - Insider Monkey
Is Merck & Co Inc. (NYSE:MRK) the Most Undervalued Quality Stock to Buy Now? - Insider Monkey
Rep. Kelly Morrison Sells Off Shares of Merck & Co., Inc. (NYSE:MRK) - Defense World
Merck & Co Inc (MRK) Stock Price, Trades & News - GuruFocus
Price Over Earnings Overview: Merck & Co - Benzinga
Merck Signs Nearly $500 Million Licensing Deal With Austria-Based Cyprumed For Tablet-Based Peptide Delivery - Benzinga
April 14, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MRK - TradingView
Merck & Co. Inc. (MRK): Among the High Growth Forever Dividend Stocks to Invest In - Yahoo Finance
Rep. Marjorie Taylor Greene Buys Merck & Co., Inc. (NYSE:MRK) Stock - Defense World
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming DeadlinesMRK - PR Newswire
Merck to Integrate Medical Resources Into Microsoft's Health Care AI Platform - MarketScreener
Is Merck & Co. (NYSE:MRK) a Cheap NYSE Stock to Invest in According to Hedge Funds? - Insider Monkey
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. - Business Wire
What to Expect From Merck & Co.'s Next Quarterly Earnings Report - TradingView
What To Expect From Merck & Co.'s Next Quarterly Earnings Report - Barchart.com
Levi & Korsinsky Notifies Shareholders of Merck & Co., Inc. (MRK) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
MRK Investors Have Final Opportunity Today to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
Is Merck & Co., Inc. (MRK) the Best Medical Stock to Buy According to Billionaires? - Insider Monkey
MRK Deadline Tomorrow: MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit - PR Newswire
FINAL MRK DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Merck & Co., Inc. Investors to Join the Class Action Lawsuit - ACCESS Newswire
Merck & Co., Inc. (NYSE:MRK) Stock Price Down 2.6%Here's What Happened - MarketBeat
MRK DEADLINE MONDAY: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Merck & Co., Inc. - Bluefield Daily Telegraph
MRK DEADLINE MONDAY: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Merck & Co., Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class Action – MRK - GlobeNewswire Inc.
Merck & Co., Inc. Investors: Please contact the Portnoy Law - GlobeNewswire
Merck & Co., Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; April 14, 2025 Deadline to file Lead Plaintiff Motion - TradingView
Jim Cramer on Merck (MRK): Stay The Course… It’s Been a Real Tough One - Yahoo Finance
MRK STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com
MRK Lawsuit Alert! Class Action Lawsuit Against Merck & Company - TipRanks
Investors who lost money on Merck & Co., Inc.(MRK) should contact Levi & Korsinsky about pending Class ActionMRK - PR Newswire
Merck (MRK) Faces Shareholder Proposals Amid Market Challenges - GuruFocus
Merck (MRK) Poised for Growth with Strong Financial Performance - GuruFocus
Merck & Co., Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. April 14, 2025 Deadline to file Lead Plaintiff Motion - TradingView
Class Action Filed Against Merck & Co., Inc. (MRK) Seeking Recovery for Investors – Contact Levi & Korsinsky - GlobeNewswire
Class Action Filed Against Merck & Co., Inc. (MRK) Seeking Recovery for Investors – Contact ... - Eagle-Tribune
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. - PR Newswire
Merck & Co., Inc. (MRK): A Bull Case Theory - Insider Monkey
Investor Sues Merck Executives, Board Over Misleading Comments - Bloomberg Law News
Merck & Co Inc Says CEO Robert M. Davis's 2024 Total Compensation Was $23.2 MillionSEC Filing - MarketScreener
MRK FINAL DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important April 14 Deadline in Securities Class Action – MRK - TradingView
Investors who lost money on Merck & Co., Inc. (MRK) should contact The Gross Law Firm about - Bluefield Daily Telegraph
Deadline Alert: Merck & Co (MRK) Investors Who Lost Money - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. - GlobeNewswire
MRK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Merck & Co., Inc. to Contact the Firm Today! - markets.businessinsider.com
Key Trends Shaping the Future of Pulmonary Arterial Hypertension Market:Merck & Co. Introduces Innovative F... - WhaTech
Rep. Gilbert Ray Cisneros, Jr. Sells Off Shares of Merck & Co., Inc. (NYSE:MRK) - Defense World
Merck & Co., Inc. (MRK): Among Defensive Stocks Billionaire Ken Fisher is Betting On - Yahoo Finance
2025-04-08 | MRK LAWSUIT ALERT: Levi & Korsinsky Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline | NYSE:MRK | Press Release - Stockhouse
MRK Stock Price and Chart — NYSE:MRK - TradingView
Infertility Drugs Market Is Booming Worldwide 2025-2032 | Merck & Co., Inc., Ferring Pharmaceuticals - openPR.com
1.17%
1.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):